Shockwave Medical (SWAV) Tops Q4 EPS by 26c

Shockwave Medical (NASDAQ: SWAV) reported Q4 EPS of $0.34, $0.26 better than the analyst estimate of $0.08. Revenue for the quarter came in at $84.2 million versus the consensus estimate of $75.43 million.

GUIDANCE:

Shockwave Medical sees FY2022 revenue of $405-425 million, versus the consensus of $386.73 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c